Genital herpes evaluation by quantitative TaqMan PCR: Correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data

Virology Journal

Volumn 7, Issue , 2010, Pages

  Aumakhan, Bulbulgul ^a   Hardick, Andrew ^b   Quinn, Thomas C ^b,c   Laeyendecker, Oliver ^b,c   Gange, Stephen J ^a   Beyrer, Chris ^a   Cox, Christopher ^a   Anastos, Kathryn ^d   Cohen, Mardge ^e   Greenblatt, Ruth M ^f   Merenstein, Daniel J ^g   Minkoff, Howard ^h   Nowicki, Marek ⁱ   Gaydos, Charlotte A ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e Department of Emergency Medicine   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^h SUNY DOWNSTATE MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS DNA;

ADULT; ARTICLE; ASSAY; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; GENITAL HERPES; GENITAL TRACT INFECTION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LAVAGE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RISK FACTOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX; VAGINA; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; EVALUATION; GENETICS; HOSPITALIZATION; ISOLATION AND PURIFICATION; METHODOLOGY; PATHOLOGY; PREVALENCE; SENSITIVITY AND SPECIFICITY; VAGINAL LAVAGE; VIROLOGY;

HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

ADULT; CERVIX UTERI; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; LONGITUDINAL STUDIES; POLYMERASE CHAIN REACTION; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VAGINA; VAGINAL DOUCHING; VIROLOGY;

EID: 78349247193     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-328     Document Type: Article

References (37)

1. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. JS Smith NJ Robinson, J Infect Dis 2002 186 Suppl 1 3 28 10.1086/343739 12353183
2. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. F Xu MR Sternberg BJ Kottiri GM McQuillan FK Lee AJ Nahmias SM Berman LE Markowitz, JAMA 2006 296 8 964 973 10.1001/jama.296.8.964 16926356
3. The impact of active herpes simplex virus infection on human immunodeficiency virus load. L Mole S Ripich D Margolis M Holodniy, J Infect Dis 1997 176 3 766 770 10.1086/517297 9291329
4. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. T Schacker J Zeh H Hu M Shaughnessy L Corey, J Infect Dis 2002 186 12 1718 1725 10.1086/345771 12447756
5. Sorting out the new HSV type specific antibody tests. RL Ashley, Sex Transm Infect 2001 77 4 232 237 10.1136/sti.77.4.232 11463920
6. Genital herpes: review of the epidemic and potential use of type-specific serology. RL Ashley A Wald, Clin Microbiol Rev 1999 12 1 1 8 9880471
7. Genital herpes simplex virus infections: clinical manifestations, course, and complications. L Corey HG Adams ZA Brown KK Holmes, Ann Intern Med 1983 98 6 958 972 6344712 (Pubitemid 13053413)
8. Recurrence rates in genital herpes after symptomatic first-episode infection. J Benedetti L Corey R Ashley, Ann Intern Med 1994 121 11 847 854 7978697
9. Duplex real-time polymerase chain reaction assay for detection and quantification of herpes simplex virus type 1 and herpes simplex virus type 2 in genital and cutaneous lesions. F Filen A Strand A Allard J Blomberg B Herrmann, Sex Transm Dis 2004 31 6 331 336 10.1097/00007435-200406000-00002 15167640
10. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. A Wald ML Huang D Carrell S Selke L Corey, J Infect Dis 2003 188 9 1345 1351 10.1086/379043 14593592
11. Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions. A Hobson A Wald N Wright L Corey, J Clin Microbiol 1997 35 3 548 552 9041386
12. Diagnosing herpesvirus infections by real-time amplification and rapid culture. GJ van Doornum J Guldemeester AD Osterhaus HG Niesters, J Clin Microbiol 2003 41 2 576 580 10.1128/JCM.41.2.576-580.2003 12574249
13. Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. RW Cone AC Hobson J Palmer M Remington L Corey, J Infect Dis 1991 164 4 757 760 1654360
14. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. RW Cone AC Hobson Z Brown R Ashley S Berry C Winter L Corey, JAMA 1994 272 10 792 796 10.1001/jama.272.10.792 8078144
15. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. MJ Slomka L Emery PE Munday M Moulsdale DW Brown, J Med Virol 1998 55 2 177 183 10.1002/(SICI)1096-9071(199806)55: 2<177::AID-JMV15>3.0.CO;2-F 9598940
16. Comparison of virus culture and the polymerase chain reaction for diagnosis of mucocutaneous herpes simplex virus infection. S Safrin H Shaw G Bolan J Cuan CS Chiang, Sex Transm Dis 1997 24 3 176 180 10.1097/00007435- 199703000-00010 9132986
17. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J Fuchs C Celum J Wang J Hughes J Sanchez F Cowan S Reid S Delany-Moretlwe L Corey A Wald HIV Prevention Trials Network 039 Protocol Team, J Infect Dis 2010 201 8 1164 1168 10.1086/651381 20214474
18. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. R Gupta A Wald E Krantz S Selke T Warren M Vargas-Cortes G Miller L Corey, J Infect Dis 2004 190 8 1374 1381 10.1086/424519 15378428 (Pubitemid 39332176)
19. Herpes simplex virus: the importance of asymptomatic shedding. DM Koelle A Wald, J Antimicrob Chemother 2000 45 Suppl T3 1 8 10.1093/jac/45.suppl-4.1 10855766
20. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons. P Leone T Warren K Hamed K Fife A Wald, Sex Transm Dis 2007 34 11 900 907 10.1097/OLQ.0b013e318063c749 17538513
21. Introduction: Is viral shedding a surrogate marker for transmission of genital herpes? SL Sacks PD Griffiths L Corey C Cohen A Cunningham GM Dusheiko S Self S Spruance LR Stanberry A Wald RJ Whitley, Antiviral Res 2004 63 Suppl 1 3 9 10.1016/j.antiviral.2004.06.002 15450380
22. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. A Wald L Corey R Cone A Hobson G Davis J Zeh, J Clin Invest 1997 99 5 1092 1097 10.1172/JCI119237 9062368
23. Viral loads of herpes simplex virus in clinical samples - a 5-year retrospective analysis. JW Tang M Lin L Chiu ES Koay, J Med Virol 2010 82 11 1911 1916 10.1002/jmv.21903 20872718
24. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. KE Mark A Wald AS Magaret S Selke L Olin ML Huang L Corey, J Infect Dis 2008 198 8 1141 1149 10.1086/591913 18783315
25. The Women's Interagency HIV Study. WIHS Collaborative Study Group. SE Barkan SL Melnick S Preston-Martin K Weber LA Kalish P Miotti M Young R Greenblatt H Sacks J Feldman, Epidemiology 1998 9 2 117 125 10.1097/00001648- 199803000-00004 9504278
26. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. N Ameli P Bacchetti RA Morrow NA Hessol T Wilkin M Young M Cohen H Minkoff SJ Gange RM Greenblatt, AIDS 2006 20 7 1051 1058 10.1097/01.aids.0000222078.75867.77 16603858
27. Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women's Interagency HIV Study (WIHS). RM Greenblatt P Bacchetti S Barkan M Augenbraun S Silver R Delapenha P Garcia U Mathur P Miotti D Burns, Sex Transm Dis 1999 26 3 143 151 10.1097/00007435- 199903000-00004 10100771
28. Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. L Corey ML Huang S Selke A Wald, J Med Virol 2005 76 3 350 355 10.1002/jmv.20365 15902702
29. Detection and typing of Herpes Simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2. L Namvar S Olofsson T Bergstrom M Lindh, J Clin Microbiol 2005 43 5 2058 2064 10.1128/JCM.43.5.2058-2064.2005 15872222
30. Limits of quantification for laboratory assays. C Cox, Appl Statist 54 63 75
31. Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers. B Aumakhan CA Gaydos TC Quinn C Beyrer L Benning H Minkoff DJ Merenstein M Cohen R Greenblatt M Nowicki K Anastos SJ Gange, PLoS One 2010 5 4 9973 10.1371/journal.pone.0009973 20376310
32. Detection, quantification and genotyping of Herpes Simplex Virus in cervicovaginal secretions by real-time PCR: a cross sectional survey [abstract]. EA Aryee RL Bailey A Natividad-Sancho S Kaye MJ Holland, Virol J 2005 2 61 10.1186/1743-422X-2-61 16095535
33. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV [abstract]. J Legoff H Bouhlal G Gresenguet H Weiss N Khonde H Hocini N Desire A Si-Mohamed J de Dieu Longo C Chemin E Frost J Pepin JE Malkin P Mayaud L Belec, J Clin Microbiol 2006 44 423 432 10.1128/JCM.44.2.423-432.2006 16455895
34. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women. N Nagot V Foulongne P Becquart P Mayaud I Konate A Ouedraogo MC Defer H Weiss P Van de Perre M Segondy, J Acquir Immune Defic Syndr 2005 39 5 632 634 16044019
35. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. M Augenbraun L Corey P Reichelderfer DJ Wright D Burns DM Koelle E Robison M Cohen Women's Health Studies 002 Study Group, Clin Infect Dis 2001 33 6 885 890 10.1086/322654 11512094
36. Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa. S Tata C Johnston ML Huang S Selke A Magaret L Corey A Wald, J Infect Dis 2010 201 4 499 504 10.1086/650302 20088691
37. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. KE Mark A Wald AS Magaret S Selke L Olin ML Huang L Corey, J Infect Dis 2008 198 8 1141 1149 10.1086/591913 18783315